| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 97, 531-547, Copyright © 1979 by American Society for Investigative Pathology
REGULAR ARTICLES |
JM Gerrard, SE Kindom, DA Peterson and JG White
In order to explore a possible relationship between platelet aggregation induced by lysophosphatidic acid (LPA) and that induced by adenosine diphosphate (ADP), we have studied the influence of palmitoyl- LPA (P-LPA) on platelets from dogs and rabbits and on human platelets made refractory to LPA. Dog platelets did not aggregate with P-LPA alone, but P-LPA enhanced ADP aggregation, and after a small dose of ADP, P-LPA was itself effective in causing aggregation and internal contraction in dog platelets. Rabbit platelets showed no response to P- LPA alone, but, as with dog platelets, P-LPA enhanced ADP aggregation. In addition, when P-LPA was added during or immediately after ADP aggregation, it caused a contraction within the platelets and a small wave of aggregation by itself. P-LPA added to human platelets caused aggregation without the need for ADP. However, when a small dose of P- LPA was added to human platelets and the wave of aggregation was allowed to reverse, these platelets subsequently were unresponsive to P- LPA, although they showed an enhanced response to ADP. The addition of a small dose of ADP to the P-LPA refractory platelets partially reversed the refractory state, and the platelets then showed aggregation with P-LPA. The results demonstrate that ADP and P-LPA have significant interactions in their effects on platelets. These interactions are discussed in terms of a two-component mechanism for the ADP-induced intracellular calcium flux, LPA, or possibly phosphatidic acid, being one component.
This article has been cited by other articles:
![]() |
Y. Xu, Y.-j. Xiao, L. M. Baudhuin, and B. M. Schwartz The Role and Clinical Applications of Bioactive Lysolipids in Ovarian Cancer Reproductive Sciences, January 1, 2001; 8(1): 1 - 13. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |